Covid19
Intranasal delivery of AstraZeneca COVID-19 vaccine fails to generate strong immune response
CanSinoBio's 'Convidecia Air' Recombinant COVID-19 vaccine (adenovirus Type 5 vector) for inhalation was approved in China in September as a …
CanSinoBio's 'Convidecia Air' Recombinant COVID-19 vaccine (adenovirus Type 5 vector) for inhalation was approved in China in September as a …